SPP 2240: Bioelectrochemical and engineering fundamentals to establish electro-biotechnolgy for biosynthesis – Power to value-added products (eBiotech)

SPP 2240：建立生物合成电生物技术的生物电化学和工程基础 â 为增值产品提供动力 (eBiotech)

• 批准号: 422694804
• 金额: --
• 依托单位: Leibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. Hans-Knöll-Institut
• 依托单位国家: 德国
• 项目类别: Priority Programmes
• 资助国家: 德国
• 项目状态: 未结题
• 来源: https://gepris.dfg.de/gepris/projekt/422694804?language=en
• 关键词: SPP; 2240; Bioelectrochemical; engineering; fundamentals

The SPP 2240 “e-Biotech” harnesses the latest advances in (bio)electrochemistry, microbiology, materials science, systems and synthetic biology and process engineering to pave the way for an emerging new field, the electro-biotechnology. It provides an immense chance to develop completely new and highly efficient bioprocesses from electricity and sustainable substrates including CO2. To this end, fundamental research, especially with an engineering approach to link the basic science with process technology, are urgently needed. The SPP timely brings together research groups with broad expertise and from different locations for a true interdisciplinary collaboration. With this e-Biotech lays the necessary foundations for realizing the promise of electro-biotechnology and enabling Germany to become internationally leading in this important area of bioeconomy and the use of regenerative energy (Power-to-Products).

SPP 2240“e-Biotech”利用（生物）电化学、微生物学、材料科学、系统和合成生物学以及过程工程的最新进展，为新兴的新领域--电生物技术铺平道路。它提供了一个巨大的机会，从电力和可持续的底物，包括二氧化碳开发全新的和高效的生物过程。为此，迫切需要进行基础研究，特别是采用工程方法将基础科学与工艺技术联系起来。SPP及时汇集了来自不同地点的具有广泛专业知识的研究小组，以实现真正的跨学科合作。电子生物技术为实现电子生物技术的前景奠定了必要的基础，并使德国在生物经济和可再生能源使用（电力到产品）这一重要领域成为国际领先地位。